Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
D04SAO
|
||||
| Former ID |
DNC000717
|
||||
| Drug Name |
GW7604
|
||||
| Drug Type |
Small molecular drug
|
||||
| Indication | Discovery agent | Investigative | [535101] | ||
| Formula |
C26H24O3
|
||||
| Canonical SMILES |
CCC(=C(C1=CC=C(C=C1)CC=CC(=O)O)C2=CC=C(C=C2)O)C3=CC=CC=<br />C3
|
||||
| InChI |
1S/C26H24O3/c1-2-24(20-8-4-3-5-9-20)26(22-15-17-23(27)18-16-22)21-13-11-19(12-14-21)7-6-10-25(28)29/h3-6,8-18,27H,2,7H2,1H3,(H,28,29)/b10-6+,26-24+
|
||||
| InChIKey |
MBIGYKCEOIJPSU-MTXYXGMBSA-N
|
||||
| PubChem Compound ID | |||||
| PubChem Substance ID | |||||
| Target and Pathway | |||||
| Target(s) | Estrogen receptor | Target Info | Antagonist | [535101] | |
| Pathway Interaction Database | Regulation of nuclear SMAD2/3 signaling | ||||
| Signaling events mediated by HDAC Class II | |||||
| Plasma membrane estrogen receptor signaling | |||||
| LKB1 signaling events | |||||
| Regulation of Telomerase | |||||
| ATF-2 transcription factor network | |||||
| AP-1 transcription factor network | |||||
| FOXM1 transcription factor network | |||||
| Validated nuclear estrogen receptor alpha network | |||||
| Signaling mediated by p38-alpha and p38-beta | |||||
| FOXA1 transcription factor network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Tang and Dr. Zhang.